Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Elżbieta Nowara"'
Publikováno v:
Contemporary Oncology, Vol 25, Iss 3, Pp 147-152 (2021)
Externí odkaz:
https://doaj.org/article/296da106802b433c99ff37ffbb890ac5
Publikováno v:
Contemporary Oncology, Vol 20, Iss 5, Pp 381-384 (2016)
Aim of the study: The presence of BRCA germline mutations in patients with ovarian cancer has been shown to have predictive and prognostic significance, including increased platinum-sensitivity. The aim of the study was to evaluate if patients with B
Externí odkaz:
https://doaj.org/article/b04f2be4a75845c39efa1f25c570d84c
Autor:
Joanna Huszno, Elżbieta Nowara
Publikováno v:
Contemporary Oncology, Vol 20, Iss 1, Pp 1-7 (2016)
The HER2/neu ( ERBB2 ) oncogene is amplified and/or overexpressed in approximately 20% of breast cancers, and is a strong prognostic factor for relapse and poor overall survival, particularly in node-positive patients. It is also an important predict
Externí odkaz:
https://doaj.org/article/1fe32d143b334dde910b116001dea117
Autor:
Joanna Huszno, Elżbieta Nowara
Publikováno v:
Menopause Review, Vol 14, Iss 3, Pp 173-177 (2015)
Introduction : Trastuzumab therapy significantly improves progression-free and overall survival in HER2-positive [HER2(+)] breast cancer (BC) patients. However, in most patients with HER2(+) metastatic BC, the disease progress occurred. The aim of th
Externí odkaz:
https://doaj.org/article/3b4eb5eb25ec4efcacdf4663ca39ee8d
Publikováno v:
Przegląd Dermatologiczny, Vol 101, Iss 3, Pp 197-200 (2014)
Introduction. Dermatofibrosarcoma protuberans (DFSP) is a rare sarcoma of the skin and subcutaneous tissue. The most common clinical problem is its local recurrence. The therapeutic procedure of choice is radical surgery. In the case of inoperable di
Externí odkaz:
https://doaj.org/article/0c51e19cbcf447ed8f4e80250191ae17
Publikováno v:
Polish Journal of Pathology, Vol 68, Iss 3, Pp 269-269 (2017)
Externí odkaz:
https://doaj.org/article/d02c855e204f4964a4c82be72f4cea08
Publikováno v:
Contemporary Oncology
Introduction Patients with cancer undergoing active systemic anticancer treatment (chemotherapy, immunotherapy, targeted, or combination therapy) are at greater risk of COVID-19 infection than persons without cancer. In this paper, the authors analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b613986dfc7e2f64668766e3b5e37388
https://doi.org/10.5114/wo.2021.109362
https://doi.org/10.5114/wo.2021.109362
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
Frontiers in Psychology
Frontiers in Psychology
Background: The number of cancer patients is constantly growing. Both WHO and IARC report that this number may reach up to 24 million new diagnosed cases in the next two decades. The proposed treatment and especially the diagnosis can have a signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d586262f89331e5a79b2f6005928aa0
https://www.frontiersin.org/articles/10.3389/fpsyg.2021.647196/full
https://www.frontiersin.org/articles/10.3389/fpsyg.2021.647196/full
Autor:
Marcin Rajczykowski, Marzenna Samborska-Plewicka, Sebastian Giebel, Grażyna Kamińska-Winciorek, Elżbieta Nowara
Publikováno v:
Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii
Introduction The use of vemurafenib in melanoma has improved the survival of patients; however, it is associated with skin toxicities. Aim To assess skin toxicities by dermoscopy in patients treated with vemurafenib. Material and methods Eight patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beca19151a08ef95cb80902d08a52da1
https://doi.org/10.5114/ada.2018.73163
https://doi.org/10.5114/ada.2018.73163
Autor:
J. Pamula Pilat, Karolina Tecza, Ewa A. Grzybowska, Elżbieta Nowara, M. Nycz Bochenek, Joanna Huszno
Publikováno v:
Cancer Research. 77:P2-07
Introduction: Somatic mutations in the TP53 gene are one of the most frequent alterations in human cancers, and germline mutations are the underlying cause of Li-Fraumeni syndrome, which predisposes to a wide spectrum of early-onset cancers. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d4159333f47c0c37e922395e3017045
https://doi.org/10.1158/1538-7445.sabcs16-p2-07-13
https://doi.org/10.1158/1538-7445.sabcs16-p2-07-13